JNJ vs PFE: Which Stock is Better?
Side-by-side comparison of Johnson & Johnson and Pfizer Inc in 2026
JNJ
Johnson & Johnson
$248.43
PFE
Pfizer Inc
$27.65
Key Metrics Comparison
| Metric | JNJ | PFE | Winner |
|---|---|---|---|
| Market Cap | $598.69B | $154.08B | JNJ |
| P/E Ratio | 22.52 | 19.93 | PFE |
| EPS (TTM) | $11.03 | $1.36 | JNJ |
| Revenue Growth | 0.1% | -0.0% | JNJ |
| Gross Margin | 68.1% | 75.8% | PFE |
Analyze JNJ
Full quant analysis
Analyze PFE
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JNJ or PFE a better investment?
Comparing JNJ and PFE: Johnson & Johnson has a market cap of $598.69B while Pfizer Inc has $154.08B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JNJ and PFE?
JNJ (Johnson & Johnson) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JNJ or PFE?
Based on P/E ratios, PFE trades at a lower multiple (19.9x vs 22.5x).
Which is growing faster: JNJ or PFE?
JNJ has higher revenue growth at 0.1% vs -0.0% for PFE.
Which company is more profitable: JNJ or PFE?
Pfizer Inc (PFE) has higher gross margins at 75.8% compared to 68.1% for JNJ.
Which is the larger company: JNJ or PFE?
Johnson & Johnson (JNJ) is larger with a market cap of $598.69B compared to $154.08B for PFE.
Should I buy JNJ or PFE in 2026?
Both JNJ and PFE have investment merit. JNJ trades at $248.43 while PFE trades at $27.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JNJ and PFE stock?
Key differences: Market Cap ($598.69B vs $154.08B), P/E Ratio (22.5x vs 19.9x), Revenue Growth (0.1% vs -0.0%), Gross Margin (68.1% vs 75.8%).